Skip to content
DraconiticResearch
Search Sources API
197,578 studies31 sourcesUpdated 28 min ago
PreprintCC BYbioRxiv

IKKα and IKKβ serve as kinase-independent scaffolds that prevent proteasomal degradation of NEMO

  1. 1The Babraham Institute

Abstract

NF-{kappa}B essential modulator (NEMO) is the critical scaffold protein of the canonical I kappa B kinase (IKK) complex. Whilst studying the contribution of IKK and IKK{beta} to NF-{kappa}B signalling we noted that NEMO protein levels were reduced in IKK knockout (KO) HCT116 cells. Loss of NEMO was more pronounced in IKK KO cells than IKK{beta} KO, whilst IKK+IKK{beta} double knockout (DKO) cells exhibited a 90% reduction in NEMO abundance. In contrast, the abundance of IKKs was unaffected by NEMO KO, although this abolished canonical NF-{kappa}B activation. Loss of IKKs had no effect on NEMO mRNA levels but IKK DKO cells exhibited accelerated NEMO protein turnover that was reversed by the proteasome inhibitor, MG132, but not the NEDDylation inhibitor, MLN4924. TAK-243, a selective inhibitor of UBA1, the E1 ubiquitin-activating enzyme, increased basal NEMO levels in DKO cells but did not prevent NEMO turnover suggesting both ubiquitylation-dependent and independent pathways for degradation. Bioinformatic analysis identified substantial regions of intrinsic disorder within the N- and C-termini of NEMO. NEMO was rapidly degraded by isolated 20S proteasomes in vitro and this was inhibited by interaction with IKK or IKK{beta}. Finally, re-expression of IKK increased NEMO expression in IKK DKO cells and this required the C-terminal NEMO binding domain (NBD) but not a functional kinase domain. Thus the IKKs act as critical kinase-independent scaffolds that stabilise NEMO; loss of these interactions results in NEMO degradation via the proteasome. These results may be relevant to strategies for inhibiting NF-{kappa}B signalling by disrupting NEMO:IKK interactions.

Related

  1. ERK5 inhibition triggers CDK6 proteasomal degradation and enhances palbociclib efficacy in cancer cells
    C. Faundez Vidiella, Y. Sfragano, I. Tusa +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. βKlotho filters ligand-independent FGFR1/4-PLCγ signaling to prevent aberrant constitutive Ca2+ entry
    Bao T. N. Dang, Phan Anh Nguyen, Subo Lee +2
    The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of PharmacologyPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  3. Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer
    S. Chakravarti, S. Mazumder, F. Hemmati +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. SARS-CoV-2 ORF9b exploits mitochondrial recruitment to TOMM70 for proteasomal protection and tunes inflammatory remodeling during lung infection
    Yining Zhao, Lauriane Kergoat, Guilherme Dias de Melo +14
    BioRxivPreprintCC BY 4.0Full textInfectious diseaseHAL
  5. The Proteasomal Switch as a Kinetic Battleground for Influenza A Virus Pathogenesis
    Sourabh Soni, Vandana Anang, Pankaj Kumar +11
    Emerging Microbes and InfectionsPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
BibTeX
@misc{cook2026ikkα,
  title = {{IKKα and IKKβ serve as kinase-independent scaffolds that prevent proteasomal degradation of NEMO}},
  author = {S. J. Cook and K. Balmanno and J. A. Prescott and N. Myers and E. J. Griffiths and Y. Shaul},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.10.750631},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.10.750631v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - IKKα and IKKβ serve as kinase-independent scaffolds that prevent proteasomal degradation of NEMO
AU  - S. J. Cook
AU  - K. Balmanno
AU  - J. A. Prescott
AU  - N. Myers
AU  - E. J. Griffiths
AU  - Y. Shaul
PY  - 2026
DA  - 2026/09/10
PB  - bioRxiv
DO  - 10.64898/2026.09.10.750631
UR  - https://www.biorxiv.org/content/10.64898/2026.09.10.750631v1
AB  - NF-{kappa}B essential modulator (NEMO) is the critical scaffold protein of the canonical I kappa B kinase (IKK) complex. Whilst studying the contribution of IKK and IKK{beta} to NF-{kappa}B signalling we noted that NEMO protein levels were reduced in IKK knockout (KO) HCT116 cells. Loss of NEMO was more pronounced in IKK KO cells than IKK{beta} KO, whilst IKK+IKK{beta} double knockout (DKO) cells exhibited a 90% reduction in NEMO abundance. In contrast, the abundance of IKKs was unaffected by NEMO KO, although this abolished canonical NF-{kappa}B activation. Loss of IKKs had no effect on NEMO mRNA levels but IKK DKO cells exhibited accelerated NEMO protein turnover that was reversed by the proteasome inhibitor, MG132, but not the NEDDylation inhibitor, MLN4924. TAK-243, a selective inhibitor of UBA1, the E1 ubiquitin-activating enzyme, increased basal NEMO levels in DKO cells but did not prevent NEMO turnover suggesting both ubiquitylation-dependent and independent pathways for degradation. Bioinformatic analysis identified substantial regions of intrinsic disorder within the N- and C-termini of NEMO. NEMO was rapidly degraded by isolated 20S proteasomes in vitro and this was inhibited by interaction with IKK or IKK{beta}. Finally, re-expression of IKK increased NEMO expression in IKK DKO cells and this required the C-terminal NEMO binding domain (NBD) but not a functional kinase domain. Thus the IKKs act as critical kinase-independent scaffolds that stabilise NEMO; loss of these interactions results in NEMO degradation via the proteasome. These results may be relevant to strategies for inhibiting NF-{kappa}B signalling by disrupting NEMO:IKK interactions.
ER  -